DSM Venturing

Founded in 2001, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

Scott Horner

Regional Managing Director North America

77 past transactions

VitaminLab

Series A in 2023
VitaminLab takes your health history, our nutrient testing or health data, and uses our matching algorithm to create an all-in-one personalized supplement that impacts your health. The company, run by a team of pharmacists and health care professionals, was founded to change the status quo of the supplement industry.

Rootine

Series A in 2022
Rootine is a precision nutrition platform that utilizes evidence-based technology to analyze biometric and lifestyle data, providing personalized nutrition recommendations. The company's approach focuses on connecting various health data points to improve individual health outcomes. By leveraging patient data, Rootine crafts tailored vitamin regimens that adapt to the unique biological needs of each person. Its artificial intelligence system continuously refines these recommendations and nutrient formulas as users' bodies change, ensuring that individuals receive optimized support for their health goals. This personalized approach aims to empower clients to make informed health decisions based on real-time data and ongoing progress tracking.

Phytolon

Series A in 2022
Phytolon Ltd, located in Misgav, Israel, specializes in the development of technology for producing natural food colorants. Founded in 2000, the company utilizes baker's yeast cells as bio-factories to create these colorants through a fermentation process. Phytolon's innovative approach aims to provide sustainable and natural alternatives for the food and beverage industry, addressing the growing demand for clean-label products.

Chinova Bioworks

Series A in 2022
Chinova Bioworks Inc. specializes in developing natural antimicrobials for the beverage industry, focusing on enhancing the shelf life of fresh juices. Founded in 2016 and based in Fredericton, Canada, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This broad-spectrum preservative effectively protects products from spoilage while remaining a healthy, natural ingredient suitable for use in foods, beverages, cosmetics, and personal care items. By providing manufacturers with a solution to improve product quality and freshness, Chinova Bioworks aims to increase consumer satisfaction and reduce food waste.

Inne

Series A in 2022
Inne is a Berlin-based biotech startup focused on developing a hormone-based mini lab designed for women to monitor their fertility. The company aims to provide a convenient and accurate method for natural contraception, enabling women to better understand their bodies and make informed choices regarding their reproductive health. Inne's innovative device analyzes fertility hormones in saliva, offering insights into ovulation, menstrual cycles, and hormone levels. By utilizing biochemistry combined with a user-friendly app, Inne empowers women to identify their fertility phases based on hormonal readings, fostering a greater awareness of their overall female health.

OK Capsule

Seed Round in 2022
OK Capsule is a provider of an online supply chain and product development software for the life science industry. Its enterprise supplement personalization platform provides custom-branded rolls of supplement packets that are more cost-effective than bottles and sustainable for the planet and are made using supplements that are ethnically sourced, fair trade, organic, kosher or halal, non-GMO and dairy, glyphosate, and soy-free that enable businesses to scale the delivery of individualized, premium-grade supplement packets to their customers that is safe for the environment and sustainable.

ATRO Medical

Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.

OK Capsule

Seed Round in 2021
OK Capsule is a provider of an online supply chain and product development software for the life science industry. Its enterprise supplement personalization platform provides custom-branded rolls of supplement packets that are more cost-effective than bottles and sustainable for the planet and are made using supplements that are ethnically sourced, fair trade, organic, kosher or halal, non-GMO and dairy, glyphosate, and soy-free that enable businesses to scale the delivery of individualized, premium-grade supplement packets to their customers that is safe for the environment and sustainable.

Rootine

Seed Round in 2021
Rootine is a precision nutrition platform that utilizes evidence-based technology to analyze biometric and lifestyle data, providing personalized nutrition recommendations. The company's approach focuses on connecting various health data points to improve individual health outcomes. By leveraging patient data, Rootine crafts tailored vitamin regimens that adapt to the unique biological needs of each person. Its artificial intelligence system continuously refines these recommendations and nutrient formulas as users' bodies change, ensuring that individuals receive optimized support for their health goals. This personalized approach aims to empower clients to make informed health decisions based on real-time data and ongoing progress tracking.

Prenexus Health

Series B in 2021
Prenexus Health, Inc. is a company specializing in the development and production of natural prebiotic ingredients aimed at enhancing digestive health and wellness. Founded in 2015 and based in Gilbert, Arizona, Prenexus Health focuses on creating branded prebiotic ingredients for use in functional foods, beverages, and dietary supplements. One of its key offerings is XOS95, a highly purified prebiotic derived from high-fiber sugarcane, which has been substantiated by scientific research for its benefits in promoting digestive health. As an innovative leader in the prebiotic space, Prenexus Health emphasizes a science-based approach, leveraging clinical research to support the efficacy of its products in improving microbiome health for various consumer goods manufacturers.

Leading Edge Equipment Technologies

Convertible Note in 2021
Leading Edge Equipment Technologies, Inc. manufactures and supplies manufacturing equipment to solar panel manufacturers. The company offers floating silicon method, which helps to reduce manufacturing cost of silicon wafers, increases commercial solar panel power, and reduces manufacturing emissions. Leading Edge Equipment Technologies, Inc. was formerly known as Leading Edge Crystal Technologies, Inc. and changed its name to Leading Edge Equipment Technologies, Inc. in May 2020. The company was founded in 2008 and is based in Wilmington, Massachusetts.

Brains Bioceutical

Series A in 2021
Brains Bioceutical Corp. engages in the production of naturally-sourced active pharmaceutical ingredients (API) for the pharmaceutical and nutraceutical industries. The company offers CBD oil, capsules, balm, and spray. It serves pharmaceutical; health and wellness; skin and beauty; and veterinary sectors. The company is based in Vancouver, Canada.

Meatable

Series A in 2021
Meatable B.V. is a food production company based in the Netherlands that specializes in the development of lab-grown meat and meat products derived from cows, chickens, and pigs. Founded in 2018, the company focuses on producing single-cell based hamburgers and aims to address concerns related to climate change, animal welfare, and food security. By utilizing innovative techniques, Meatable seeks to provide a sustainable alternative to traditional meat production, allowing consumers to enjoy real meat without compromising ethical or environmental standards. Through its efforts, the company aspires to satisfy the global demand for meat while promoting a more responsible and guilt-free approach to food consumption.

Deep Branch Biotechnology

Series A in 2021
Deep Branch Biotechnology Ltd., founded in 2018 and based in Nottingham, United Kingdom, with additional offices in the Netherlands, specializes in carbon recycling services. The company has developed scalable technology that converts carbon dioxide from industrial waste gas into clean, nutritious, and sustainable single-cell protein. This innovative process not only helps to reduce the carbon footprint of polluting industries but also offers sustainable alternatives to traditional feed sources such as soy and fishmeal. By transforming emissions into valuable protein, Deep Branch Biotechnology aims to contribute to a more sustainable future in the feed industry.

Novum Medical

Venture Round in 2021
Novum Medical is a privately-held medical device company based in Woburn, Massachusetts, specializing in innovative bone graft substitute products designed for spine and foot and ankle surgeries. Utilizing its proprietary Cross-Linked Microstructure (CLM) technology, Novum Medical develops biocompatible materials that exhibit enhanced mechanical and biological properties, facilitating effective surgical solutions. The company's product pipeline includes a variety of bone graft substitutes such as beta and epsilon wedges for mid-foot osteotomies, as well as devices for the surgical repair of hammertoe deformity and interbody devices for spinal fusion. Established in 2009, Novum Medical is committed to advancing musculoskeletal clinical practice through rapid and cost-effective component fabrication methods.
Additive Manufacturing Technologies specializes in automated post-processing solutions for 3D printed parts, targeting high-volume production across various industrial sectors. The company integrates advancements in material science, chemistry, hardware engineering, robotics, and machine learning to enhance the quality and reliability of 3D printed components. By focusing on the post-processing phase, AMT helps companies optimize their additive manufacturing facilities, improving efficiency and reducing lead times and manufacturing costs. Their technology supports a seamless digital workflow, enabling clients to meet market-ready specifications effectively and scale up production capabilities.

Frontier Nutrition

Series B in 2021
Frontier Nutrition, Inc. is a company based in Dover, Delaware, that focuses on developing, manufacturing, and marketing fortified packaged food products aimed at addressing the nutritional needs of low and middle-income households in underserved communities globally. Established in 2016, Frontier Nutrition creates innovative and culturally relevant recipes that cater to traditional diets while optimizing for taste, nutrition, and affordability. The company’s mission is to combat early life and maternal malnutrition by providing low-cost and convenient food options for families facing challenges such as limited access to healthcare, transportation, and clean water. Through cutting-edge research in pediatric nutrition and behavioral marketing, Frontier Nutrition strives to improve the overall well-being and sustainable living standards of families in frontier markets.
Leading Edge Equipment Technologies, Inc. manufactures and supplies manufacturing equipment to solar panel manufacturers. The company offers floating silicon method, which helps to reduce manufacturing cost of silicon wafers, increases commercial solar panel power, and reduces manufacturing emissions. Leading Edge Equipment Technologies, Inc. was formerly known as Leading Edge Crystal Technologies, Inc. and changed its name to Leading Edge Equipment Technologies, Inc. in May 2020. The company was founded in 2008 and is based in Wilmington, Massachusetts.

NutriLeads

Series B in 2020
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

Phynova

Venture Round in 2020
Phynova is a British life science company that develops and commercialises natural healthcare products derived from active compounds found in plants. Founded in 2002, Phynova is an innovative life science company based in Oxford, UK with a subsidiary research company located in Beijing, China. Phynova develops and commercialises natural healthcare products derived from active compounds found in plants. Phynova develops products for use in global healthcare and FMCG markets. It identifies active ingredients from plants with a rich history of use in traditional medicine, especially in China, and develops solutions for global health concerns.

Panaceutics Inc.

Series A in 2020
Panaceutics Inc. engages in formulation, manufacturing, and distribution of medicines. The company offers technology to transform multiple pills into a single packet of easy-to-swallow fruit puree for macro nutrient needs. It serves to healthcare systems, integrated delivery partners, pharmaceutical companies, and nutritional product manufacturers. The company was founded in 2013 and is based in Research Triangle Park, North Carolina.

Inkbit

Venture Round in 2019
Inkbit Corporation is a Medford, Massachusetts-based company focused on the research, development, and manufacturing of advanced 3D printers. Founded in 2017, the company has created a next-generation additive manufacturing platform that integrates machine learning and artificial intelligence with material jetting technology. By leveraging the expertise of MIT-trained scientists and engineers in industrial systems, design software, and material science, Inkbit aims to bridge the gap between prototyping and full-scale production. Its platform utilizes machine vision to offer rapid, on-demand manufacturing of multi-material and end-use polymer parts, catering to the needs of demanding industrial applications.

Voxel8

Series B in 2019
Voxel8 Inc. is a company focused on advancing 3D printing technology by integrating electronic functionalities into traditional 3D printed structures. Established in 2013 and located in Somerville, Massachusetts, Voxel8 designs and manufactures desktop 3D printers capable of printing thermoplastics and UV resins. The company specializes in innovative materials that enable the embedding of conductors, wires, and batteries within standard 3D printing matrices, based on research from Harvard University. Additionally, Voxel8 offers Project Wire, a cloud-based software tool that assists users in designing 3D printable electronic devices that can be efficiently produced using their printers.

Voxel8

Series B in 2019
Voxel8 Inc. is a company focused on advancing 3D printing technology by integrating electronic functionalities into traditional 3D printed structures. Established in 2013 and located in Somerville, Massachusetts, Voxel8 designs and manufactures desktop 3D printers capable of printing thermoplastics and UV resins. The company specializes in innovative materials that enable the embedding of conductors, wires, and batteries within standard 3D printing matrices, based on research from Harvard University. Additionally, Voxel8 offers Project Wire, a cloud-based software tool that assists users in designing 3D printable electronic devices that can be efficiently produced using their printers.
Additive Manufacturing Technologies specializes in automated post-processing solutions for 3D printed parts, targeting high-volume production across various industrial sectors. The company integrates advancements in material science, chemistry, hardware engineering, robotics, and machine learning to enhance the quality and reliability of 3D printed components. By focusing on the post-processing phase, AMT helps companies optimize their additive manufacturing facilities, improving efficiency and reducing lead times and manufacturing costs. Their technology supports a seamless digital workflow, enabling clients to meet market-ready specifications effectively and scale up production capabilities.

Chinova Bioworks

Seed Round in 2019
Chinova Bioworks Inc. specializes in developing natural antimicrobials for the beverage industry, focusing on enhancing the shelf life of fresh juices. Founded in 2016 and based in Fredericton, Canada, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This broad-spectrum preservative effectively protects products from spoilage while remaining a healthy, natural ingredient suitable for use in foods, beverages, cosmetics, and personal care items. By providing manufacturers with a solution to improve product quality and freshness, Chinova Bioworks aims to increase consumer satisfaction and reduce food waste.

ZeaVision

Venture Round in 2019
ZeaVision develops products for EyeCare Professionals and patients. ZeaVision's mission is to develop and market science-based supplements and vision care products to support healthy vision and prevent vision loss in the lives of many.

Panaceutics Inc.

Venture Round in 2019
Panaceutics Inc. engages in formulation, manufacturing, and distribution of medicines. The company offers technology to transform multiple pills into a single packet of easy-to-swallow fruit puree for macro nutrient needs. It serves to healthcare systems, integrated delivery partners, pharmaceutical companies, and nutritional product manufacturers. The company was founded in 2013 and is based in Research Triangle Park, North Carolina.

Hyalex Orthopaedics

Series A in 2019
Hyalex Orthopaedics, Inc. is a medical device company based in Lexington, Massachusetts, focused on developing innovative products that utilize HYALEX technology, a synthetic polymer engineered to mimic cartilage. Founded in 2016, the company specializes in creating a biomimetic material that can effectively simulate healthy cartilage to treat diseased or damaged joints. The unique properties of HYALEX allow it to maintain low friction and wear, even under the significant loads typically experienced in human joints. This capability enables surgeons to replace arthritic cartilage while preserving healthy bone. Although Hyalex Orthopaedics is advancing its product development, its offerings have not yet received approval for use in humans from any regulatory agency.

Adaptive3D

Series A in 2019
Adaptive3D is a leading supplier of premium additive manufacturing polymer resins, focusing on enabling high-volume production through optimized materials. The company specializes in rubber-like 3D printable materials, damping materials, and low-cure stress photopolymers. By leveraging innovative technologies, Adaptive3D provides high-quality polymer resins and specialty polymers that empower clients to create differentiated products with exceptional part performance. Their solutions are designed for both functional end-use products and prototypes, allowing for precise internal geometries and economically customized parts. Through partnerships with global leaders, Adaptive3D is committed to advancing the capabilities of additive manufacturing.

Raycatch

Series B in 2018
Raycatch Ltd. is an Israeli company that specializes in AI diagnostics technology for the solar energy sector. The company has developed an automated software-as-a-service platform that transforms the management of solar assets by analyzing existing data to facilitate on-demand maintenance and operational efficiency. Its application, DeepSolar™, provides daily analysis of production data, delivering comprehensive diagnostic insights for photovoltaic (PV) portfolios. These insights cover various aspects such as component performance, maintenance needs, and operational efficiencies, allowing solar plant owners to enhance energy yield and reduce operational costs without the need for hardware installation or site visits. By automating the decision-making process for solar asset management, Raycatch aims to improve profitability and promote the broader adoption of solar energy in the global market.

Miach Orthopaedics

Series A in 2018
Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury. Miach Orthopaedics was founded on 2016 and is headquartered in Westborough, Massachusetts.

Novum Medical

Series C in 2018
Novum Medical is a privately-held medical device company based in Woburn, Massachusetts, specializing in innovative bone graft substitute products designed for spine and foot and ankle surgeries. Utilizing its proprietary Cross-Linked Microstructure (CLM) technology, Novum Medical develops biocompatible materials that exhibit enhanced mechanical and biological properties, facilitating effective surgical solutions. The company's product pipeline includes a variety of bone graft substitutes such as beta and epsilon wedges for mid-foot osteotomies, as well as devices for the surgical repair of hammertoe deformity and interbody devices for spinal fusion. Established in 2009, Novum Medical is committed to advancing musculoskeletal clinical practice through rapid and cost-effective component fabrication methods.

Chinova Bioworks

Seed Round in 2018
Chinova Bioworks Inc. specializes in developing natural antimicrobials for the beverage industry, focusing on enhancing the shelf life of fresh juices. Founded in 2016 and based in Fredericton, Canada, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This broad-spectrum preservative effectively protects products from spoilage while remaining a healthy, natural ingredient suitable for use in foods, beverages, cosmetics, and personal care items. By providing manufacturers with a solution to improve product quality and freshness, Chinova Bioworks aims to increase consumer satisfaction and reduce food waste.

Chromatic 3D Materials

Series A in 2018
Chromatic 3D Materials specializes in developing advanced 3D printing materials that enhance the durability and functionality of manufactured goods. The company focuses on an additive manufacturing platform that produces robust rubber parts using innovative elastomer materials, including polyurethanes. This technology employs reactive extrusion additive manufacturing, which leverages chemical reactions to create industrial-strength elastomeric components. As a result, manufacturers gain access to materials that exhibit adaptability, resilience, flexibility, and sustainability, allowing for a wide range of novel product designs. Chromatic 3D Materials aims to transform the landscape of 3D printing by providing the necessary materials for creating durable and functional designs.

Tespo

Series A in 2018
At Tespo, they create innovative products for customers to help improve their quality of life and deliver an experience that exceeds their expectations. Tespo’s system provides all the storage, convenience and daily use benefits of a vitamin pill without the drawbacks - no fillers, binders, additives or unnecessary ingredients. By leveraging a disc/dispenser design - Tespo provides an individual liquid vitamin serving everyday delivered straight to your door each month.
Leading Edge Equipment Technologies, Inc. manufactures and supplies manufacturing equipment to solar panel manufacturers. The company offers floating silicon method, which helps to reduce manufacturing cost of silicon wafers, increases commercial solar panel power, and reduces manufacturing emissions. Leading Edge Equipment Technologies, Inc. was formerly known as Leading Edge Crystal Technologies, Inc. and changed its name to Leading Edge Equipment Technologies, Inc. in May 2020. The company was founded in 2008 and is based in Wilmington, Massachusetts.

ATRO Medical

Series A in 2017
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.

NutriLeads

Series A in 2017
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

QD Solar

Series A in 2017
The solar photovoltaic market is one of the fastest growing energy markets in the world. That growth comes amidst the race to the bottom on cell and module pricing driven by fierce supply side market competition. PV manufacturers can no longer count on economies of scale and incremental process improvements to attain profit in the face of competitive pricing pressures. Manufacturers need to differentiate their product by delivering better performance for the same or lower cost. QD Solar, a University of Toronto spinoff company, will provide this differentiation.

WattGlass

Series A in 2017
WattGlass LLC, founded in 2014 and based in Fayetteville, Arkansas, specializes in developing innovative water-based anti-reflective coatings designed to eliminate reflection, glare, and fogging on glass and other transparent materials. The company's proprietary nanoparticle technology, initially developed during research at the University of Arkansas, offers a safe and environmentally friendly alternative to hazardous materials typically used in coatings. WattGlass's solutions cater to various industries, including automotive, consumer goods, architectural glass, and solar photovoltaic applications. The company has secured exclusive licensing for its technology and has filed multiple patents to further enhance its product offerings.

Essential Medical

Series B in 2016
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in developing femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has created two primary closure devices, including MANTA, which is specifically designed to address large bore punctures ranging from 10 to 24 French. These devices are particularly relevant for procedures such as transcatheter aortic valve replacement (TAVR), abdominal aortic aneurysm repair (AAA/PVAR), and balloon aortic valvuloplasty (BAV). The innovations from Essential Medical aim to fulfill a significant need in interventional cardiology by providing efficient closure solutions that minimize complications for patients. Since October 2018, the company operates as a subsidiary of Teleflex Incorporated.

Blue Prairie

Series A in 2016
Blue Prairie Brands LLC, based in Charlottesville, Virginia, specializes in the manufacture of inulin, a prebiotic ingredient known for its health benefits. The company produces soluble, indigestible fibers that enhance the nutritional content of various food products, beverages, and dietary supplements. Their flagship product is a gluten-free, non-GMO form of inulin, which supports digestive health when combined with probiotics. Additionally, Blue Prairie's innovative approach to production offers farmers a profitable rotation crop that aligns with their existing agricultural practices. By focusing on functional foods and dietary fiber, Blue Prairie Brands aims to improve the nutritional value of products in the market while promoting a healthy gut environment.

Arecor

Venture Round in 2016
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in the development of innovative stabilization technology solutions for pharmaceutical and biotech firms. The company partners with these organizations to enhance the commercial value and utility of proteins used in various applications, including vaccines, therapeutic proteins, and treatments for complex diseases. Arecor focuses on developing products for areas such as diabetes, oncology, immunology, and infectious diseases, working to reformulate existing therapies to improve their efficacy and ease of use. Its innovative formulation technology enables high concentrations of antibodies for at-home self-administration and stable liquid formulations for biological therapies. Arecor also addresses challenges related to protein degradation and stability, particularly in the formulation of growth hormones and vaccines. Founded in 2006, Arecor operates primarily in the UK and has a global reach, collaborating with leading pharmaceutical and biotech companies to deliver enhanced therapeutic solutions.

NOMADD

Series A in 2016
NOMADD specializes in innovative cleaning solutions for solar panels in desert environments. The company has developed the NO-water Mechanical Automated Dusting Device, a system designed to address the unique challenges posed by dust accumulation in arid climates. This automated device allows for effective cleaning of solar panels without the use of water, ensuring that the panels remain undamaged while maintaining their efficiency. NOMADD's technology originated from research conducted at the King Abdullah University for Science and Technology, located near Jeddah, Saudi Arabia. The company's focus on waterless cleaning solutions positions it as a key player in the solar energy sector, particularly in regions where traditional cleaning methods may be impractical.

NutriLeads

Seed Round in 2015
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

NovoPolymers

Venture Round in 2015
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Natreon

Venture Round in 2015
Natreon, Inc. specializes in the development and marketing of Ayurvedic products, focusing on dietary supplements derived from traditional herbal ingredients. The company offers a range of products, including CAPROS, an antioxidant for cardiovascular health; SENSORIL, an anti-stress Ashwagandha blend; AYUFLEX for joint health; and PRIMAVIE, a mitochondrial energy booster. Natreon's formulations are backed by extensive research, clinical studies, and safety evaluations, ensuring a high degree of standardization. The company holds patents for its products both in the United States and internationally. Founded in 1998, Natreon is headquartered in New Brunswick, New Jersey, and operates a state-of-the-art research and development facility in Kolkata, India.

Interface Biologics

Series B in 2015
Interface Biologics, Inc. (IBI) is a commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. Their patent-protected technologies include anti-thrombogenic additives for blood contacting medical devices and polymer enabled combination drug delivery devices. IBI has exclusive Endexo™ technology licensing agreements with AngioDynamics for vascular access catheters and with Fresenius Medical Care for chronic dialysis systems. AngioDynamics’ BioFlo PICCS, Ports and DuraMax Dialysis Catheter with IBI’s Endexo technology have received FDA clearance and are gaining commercial traction. IBI also has a joint venture commercial agreement with Qualimed to develop a drug-coated balloon based on IBI’s Kinesyx™ technology. The company was founded in 2001 and is headquartered in Toronto, Canada at the acclaimed MaRS Innovation Centre.

EyePromise

Venture Round in 2014
EyePromise is a manufacturer of dietary supplements focused on promoting ocular health and combating age-related vision loss. The company specializes in zeaxanthin supplements, which are designed for individuals at risk of developing age-related macular degeneration. EyePromise offers a range of products, including the EyePromise restore supplement, targeted for professional use, and EyePromise ten, which caters to consumers seeking zeaxanthin. Additionally, EyePromise provides the QuantifEYE program, a tool for assessing the risk of vision deterioration. Through its offerings, EyePromise aims to enhance visual performance, alleviate dry eyes, and support overall vision health.

Verdezyne

Venture Round in 2014
Verdezyne is a company focused on synthetic biology, utilizing its expertise to develop innovative solutions for producing chemicals from renewable sources. By leveraging advanced computational algorithms and proprietary gene libraries, Verdezyne engineers proteins and metabolic pathways to optimize fermentation processes. This approach allows the company to create sustainable alternatives to petrochemicals, significantly reducing reliance on oil. Its platform integrates proven manufacturing technologies to generate a diverse range of chemical building blocks and additives that are applicable in various everyday products. Through its efforts, Verdezyne aims to provide cost-effective and environmentally friendly chemical solutions.

Isobionics

Venture Round in 2014
Isobionics B.V. develops, produces, and sells natural products for customers in flavor and fragrance market. It produces compounds, such as citrus oils that include lemon, orange, and grapefruit; compounds, including valencene and nootkatone, menthol, sandalwood oil, and patchouli oil; and other basic building blocks for the flavor and fragrance industry. The company was founded in 2008 and is based in Geleen, the Netherlands. As of September 26, 2019, Isobionics B.V. operates as a subsidiary of BASF SE.

ChromaDex

Post in 2013
ChromaDex Corporation is a nutraceutical company focused on promoting healthy aging through innovative ingredients and scientific research. It is best known for its flagship product, Nicotinamide riboside (NIAGEN), a form of vitamin B3 that helps enhance levels of nicotinamide adenine dinucleotide (NAD+), which naturally decline with age. The company also offers Immulina, a spirulina extract aimed at boosting immune function. ChromaDex operates through three primary segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the bulk of its revenue generated from the Consumer Products segment. The company is involved in developing and commercializing patented ingredient technologies for various markets, including dietary supplements, food, beverages, skincare, and pharmaceuticals. Alongside its product offerings, ChromaDex provides analytical testing and regulatory consulting services, reinforcing its commitment to quality and safety in its ingredient development. Headquartered in Los Angeles, California, ChromaDex continues to leverage its extensive intellectual property and scientific backing in the biosciences sector.

Arecor

Venture Round in 2013
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in the development of innovative stabilization technology solutions for pharmaceutical and biotech firms. The company partners with these organizations to enhance the commercial value and utility of proteins used in various applications, including vaccines, therapeutic proteins, and treatments for complex diseases. Arecor focuses on developing products for areas such as diabetes, oncology, immunology, and infectious diseases, working to reformulate existing therapies to improve their efficacy and ease of use. Its innovative formulation technology enables high concentrations of antibodies for at-home self-administration and stable liquid formulations for biological therapies. Arecor also addresses challenges related to protein degradation and stability, particularly in the formulation of growth hormones and vaccines. Founded in 2006, Arecor operates primarily in the UK and has a global reach, collaborating with leading pharmaceutical and biotech companies to deliver enhanced therapeutic solutions.

Segetis

Series C in 2012
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, focused on the development, production, and commercialization of renewable polymers. Founded in 2006, the company utilizes a platform of binary monomers derived from renewable feedstocks, including non-food agricultural and forestry sources. Segetis's technology supports the production of a range of materials, such as bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, contributing to the advancement of industrial bioproducts. The company's innovations provide opportunities for synergies within various industries, including those involved in processing starch, sugar crops, wood, cellulose, and vegetable oils, as well as the manufacture of biodiesel and linear alpha-olefins.

Xolve

Funding Round in 2012
Xolve, Inc., a nanomaterials company, produces and supplies graphene that is used to improve the properties of various industrial plastics for use in automotive, aerospace, electronics, and other applications. It offers graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene. Xolve, Inc. was formerly known as Graphene Solutions, Inc. and changed its name to Xolve, Inc. in September 2010. The company was founded in 2008 and is based in Middleton, Wisconsin. As of March 31, 2016, Xolve, Inc. operates as a subsidiary of Reliance Industries Limited.

Regentis Biomaterials

Series C in 2012
Regentis Biomaterials Ltd. is a tissue repair company specializing in the development and commercialization of biodegradable hydrogels aimed at regenerating damaged cartilage tissue. The company's primary product, GelrinC, is a hydrogel designed for the treatment of articular cartilage lesions and is currently undergoing clinical trials. GelrinC serves a range of orthopedic applications, including microfracture and autologous chondrocyte implantation procedures. The hydrogel platform, Gelrin, combines polyethylene glycol diacrylate and denatured fibrinogen, offering both the stability of synthetic materials and the bio-functionality of natural substances. Founded in 2004, Regentis Biomaterials is headquartered in Or-Akiva, Israel, with an additional office in Princeton, New Jersey. The company is committed to enhancing patient health and quality of life through innovative tissue repair solutions.

Verdezyne

Venture Round in 2011
Verdezyne is a company focused on synthetic biology, utilizing its expertise to develop innovative solutions for producing chemicals from renewable sources. By leveraging advanced computational algorithms and proprietary gene libraries, Verdezyne engineers proteins and metabolic pathways to optimize fermentation processes. This approach allows the company to create sustainable alternatives to petrochemicals, significantly reducing reliance on oil. Its platform integrates proven manufacturing technologies to generate a diverse range of chemical building blocks and additives that are applicable in various everyday products. Through its efforts, Verdezyne aims to provide cost-effective and environmentally friendly chemical solutions.

CellMade

Funding Round in 2010
CellMade SAS is a biopharmaceutical company based in Chappes, France, with additional facilities in Marseille and Ruffieux. Founded in 2007, the company specializes in developing and supplying a range of cell biology products, including human-origin primary cells and various types of specialized cells such as blood cells, endothelial cells, and pancreatic cells. CellMade also offers laboratory services that encompass biobanking, cell-based assays, cytometry, and mass spectrometry. The company invests in its research and development initiatives through its CellInsight platform, which focuses on identifying targets and biomarkers associated with inflammatory pathologies. By providing customized cell isolation and co-culture models, CellMade aims to advance the field of cell biology and support various research applications.

Segetis

Series B in 2010
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, focused on the development, production, and commercialization of renewable polymers. Founded in 2006, the company utilizes a platform of binary monomers derived from renewable feedstocks, including non-food agricultural and forestry sources. Segetis's technology supports the production of a range of materials, such as bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, contributing to the advancement of industrial bioproducts. The company's innovations provide opportunities for synergies within various industries, including those involved in processing starch, sugar crops, wood, cellulose, and vegetable oils, as well as the manufacture of biodiesel and linear alpha-olefins.

Novomer

Series B in 2009
Novomer is a materials company focused on developing high-performance, eco-friendly plastics, polymers, and chemicals. Established in 2004 and based in Waltham, Massachusetts, the company leverages proprietary catalytic technology to convert carbon dioxide and other renewable materials into cost-effective industrial products. This innovative approach combines traditional chemical feedstocks with carbon, enabling the sustainable synthesis of a range of chemicals and materials. Novomer’s technology not only offers competitive pricing but also contributes to environmental sustainability by addressing global warming and climate change challenges through the use of carbon in industrial applications.

Viocare

Venture Round in 2009
Viocare, Inc. is a privately-held company bringing the benefits of cutting edge knowledge in the nutrition and behavior change sciences to the development of breakthrough web and mobile solutions that serve both researchers and the preventive care market.

Provexis

Post in 2008
Provexis is a company that develops, licenses, and markets functional foods, medical foods, and dietary supplements. Its flagship product, Fruitflow, is a tomato extract designed to reduce the risk of abnormal blood clotting, which is often linked to cardiovascular diseases like heart attacks and strokes. Fruitflow is available in syrup and powder forms and is incorporated into various food, beverage, and dietary supplement formats. The company also offers Fruitflow + Omega-3, a capsule supplement that promotes healthy blood flow and normal heart function. Provexis collaborates with By-Health Co., Ltd. to expand its reach and offers its products through retail outlets and online platforms. Founded in 1999, Provexis is headquartered in Reading, United Kingdom.

Ganeden, Inc.

Venture Round in 2007
Ganeden, Inc. specializes in the development and supply of probiotics and probiotic bacteria for various applications, including functional foods, beverages, dietary supplements, and personal care products. The company offers a range of products, such as GanedenBacillus coagulans for food and animal health, Bonicel for anti-aging skincare, and Staimune for immune support. Founded in 1997 and based in Mayfield Heights, Ohio, Ganeden has established a strong presence in the market by launching a successful line of over-the-counter products, including Digestive Advantage and Sustenex, which have sold nearly 200 million doses through extensive retail distribution. The company also maintains a strategic alliance with Sensus America and operates as a subsidiary of Kerry Group plc, focusing on innovative probiotic solutions that aim to enhance health and well-being.

Upfront Chromatography

Venture Round in 2007
Upfront Chromatography is a Denmark-based biotech company with significant expertise and regulatory experience in the development of customised industrial processes. Upfront develops and manufactures innovative products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells, directly from bioreactors and industrial side-streams.
Food Quality Sensor International, Inc. is a sensor technology company based in Lexington, Massachusetts, that specializes in the development and commercialization of real-time devices for measuring food freshness. Founded in 2004, the company offers products such as SensorQ, which assesses the freshness of meat and poultry within their packaging, and SensorfreshQ, a handheld electronic nose designed to detect spoilage in these products. Its clientele spans various sectors, including food processing, grocery distribution, food service, regulatory agencies, defense, and consumer retail markets, highlighting its commitment to enhancing food safety and quality.

Harland Medical Systems

Private Equity Round in 2007
Harland Medical Systems, Inc. specializes in surface enhancement products for the healthcare industry, focusing on medical device coatings and related services. Founded in 2002 and headquartered in Eden Prairie, Minnesota, the company offers a range of solutions including antimicrobial coatings, coating materials for surface modification, and method development services for medical devices. Harland Medical Systems provides various coating systems for applying ultraviolet cured coatings, along with friction test equipment to assess the performance of lubricious coatings on devices such as catheters and guide wires. The company serves a diverse clientele across multiple clinical markets including neurology, urology, cardiology, wound care, and endoscopy, aiming to enhance patient outcomes and improve the economic value of healthcare products and procedures.

Micromuscle

Venture Round in 2006
Micromuscle AB, established in 2000, specializes in the development of innovative biomedical products utilizing its proprietary electroactive polymer technology, known as MICROMUSCLE technology. This technology enables electroactive polymers to expand and contract in response to an electric potential, making it particularly suitable for various vascular applications. The company's focus on electro-active polymers positions it at the forefront of biomedical advancements, aiming to enhance medical treatments and devices through its unique material properties.

IntegraGen

Venture Round in 2006
IntegraGen is a French biotechnology company located in the Genopole life science park in Evry, near Paris. The company specializes in the development of genetic biomarkers and utilizes its proprietary technology platforms to provide a range of genomics services. IntegraGen offers bioinformatics, clinical research, and human genetic research services, along with solutions for agrigenomics and microbiologic research. Its unique intellectual property and access to extensive sample libraries enable the company to focus on developing molecular markers for central nervous system and metabolic diseases. IntegraGen serves the pharmaceutical and biotech industries, along with other research providers, contributing to advancements in genomic research and applications.

Sciona

Series C in 2006
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

ORYXE Energy International

Venture Round in 2005
ORYXE Energy International was founded in 2001 to solve the world’s dual need for dependable fuel supplies and a cleaner environment. By focusing on a specific challenge—cleaner-burning fuels—they have developed innovative additive technologies that improve fuel performance and make a meaningful reduction in toxic emissions from renewable and fossil fuels. Their products are proven, safe, cost-effective and available worldwide.

Sciona

Series B in 2004
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Morphotek

Series C in 2004
Morphotek is a prominent life science company focused on developing innovative biological products for the treatment of cancer, inflammatory conditions, and infectious diseases. Established in 2000, Morphotek specializes in the discovery and development of monoclonal antibodies (mABs) and conducts research and clinical development programs for its own drug candidates. The company targets various ailments, including ovarian and pancreatic cancers, rheumatoid arthritis, and asthma. The foundation of Morphotek's technology lies in morphogenics, co-invented by Dr. Nicholas Nicolaides during his post-graduate studies at Johns Hopkins Medical School, alongside co-founders Dr. Philip Sass and Dr. Luigi Grasso. This proprietary technology has significantly advanced Morphotek's capabilities in creating novel pharmaceutical products and therapeutic targets.

Optiva

Series C in 2003
Optiva Inc. is a provider of cloud-native revenue management software tailored for communication service providers (CSP) across various global regions, including Europe, the Middle East, Africa, North America, Latin America, the Caribbean, Asia, and the Pacific Rim. The company's solutions facilitate real-time billing, charging, policy management, and enhanced user experiences. Notable products include the Optiva Charging Engine, which aids CSPs in monetizing next-generation services; the Optiva Policy Management solution, designed for data monetization in applications like video streaming and voice over LTE; and Optiva Wholesale Settlement, a cloud solution for accurate interconnect billing. Additionally, Optiva offers e-payment solutions and a comprehensive Business Support Systems Platform for converged billing. Founded in 1999 and headquartered in Mississauga, Canada, Optiva Inc. aims to support the growth and performance of its telecommunications customers through innovative software solutions.

Sciona

Series A in 2002
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.